Clinical trials: Chorioretinopathy
Anterior Uveitis (AU), Birdshot Chorioretinitis
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of…
- Conditions
- Anterior Uveitis (AU), Birdshot Chorioretinitis, Behcet Disease, Herpes Simplex Virus
- Trial name
- NCT07065747
- Where
- United States
- Volunteers
- 125 people, healthy volunteers welcome
- Sponsor
- Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy
OCT in Rare Chorioretinal Diseases
This study will evaluate the total blood flow in the retina and choroid (structures in the back of the eye) by Doppler optical coherence tomography (OCT) and OCT angiography. Angiography is mapping of the blood vessels.
- Conditions
- Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia
- Trial name
- NCT02141308
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- Oregon Health and Science University
Central Serous Chorioretinopathy, Selective Retina Therapy
Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy
The purpose of this study is to evaluate the efficacy of Selective Retina Therapy (SRT) for treating acute idiopathic central serous chorioretinopathy (ICSC).
- Trial name
- NCT00987077
- Testing
- Selective Retina Therapy (SRT)
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- University of Kiel
Chronic Central Serous Chorioretinopathy
Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy
Chronic central serous chorioretinopathy (cCSC) is a relatively frequently occurring eye disease that is often diagnosed in patients in the professionally active age range.
- Trial name
- SPECT (NCT03079141)
- Testing
- Eplerenone, Photodynamic therapy
- Where
- 3 sites in Netherlands
- Volunteers
- 107 people
- Sponsor
- Leiden University Medical Center
Central Serous Chorioretinopathy
Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy
describing the influence of; combined Eplerenone, intravitreal Aflibercept, and topical Nepafenac; on serous foveal detachment in eyes with CSCR
- Trial name
- CSCR (NCT05847049)
- Testing
- Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
- Where
- Egypt
- Volunteers
- 16 people
- Sponsor
- Dar El Oyoun Hospital
Central Serous Chorioretinopathy
Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC)
Optical Coherence Tomography Angiography (OCT-A) is a noninvasive imaging technique that allows one to see blood vessels in the retina.
- Trial name
- OPACITY (NCT03950089)
- Testing
- Optical Coherence Tomography Angiography (OCT-A)
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon
Central Serous Chorioretinopathy
Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
The purpose of this study is to examine the effects of Lucentis for active Central Serous Chorioretinopathy.
- Trial name
- NCT00403325
- Testing
- rhuFab V2 [ranibizumab] ( Lucentis )
- Where
- United States
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- Vitreous -Retina- Macula Consultants of New York
Central Serous Chorioretinopathy
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
To investigate the potential association between gut microbiota and central serous chorioretinopathy (CSC), clinical observations have indicated that patients with CSC frequently present with chronic gastrointestinal symptoms.
- Trial name
- NCT06527326
- Testing
- Live Combined Bifidobacterium
- Where
- China
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Acute Central Serous Retinopathy With Subretinal Fluid
Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy
To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).
- Trial name
- NCT05447117
- Testing
- Micropulse laser
- Where
- Egypt
- Volunteers
- 42 people
- Sponsor
- Minia University
Retinal Disease
Evaluation and Treatment of Patients With Retinal Disease
This study offers evaluation and treatment for patients with certain diseases of the retina (the layer of light-sensitive tissue that lines the inside of the eyeball).
- Trial name
- NCT00005784
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- National Eye Institute (NEI)
the Presence of Subretinal Fluid (SRF)
Green Subthreshold Laser Therapy for Chronic Central Serous Chorioretinopathy.
Chronic Central Serous Chorioretinopathy (CSCR) is a vision-threatening retinal disorder characterized by persistent subretinal fluid due to choroidal vascular hyperpermeability and retinal pigment epithelium (RPE) dysfunction.
- Trial name
- NCT07020793
- Testing
- green subthreshold laser therapy
- Where
- Italy
- Volunteers
- 12 people
- Sponsor
- Federico II University